Journal article · 2000 · Open access

Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy

Valerie A. Jenkins, Lesley J. Fallowfield

British Journal of Cancer, 82(11), 1783–1788 · Published 5 May 2000 · DOI 10.1054/bjoc.2000.1142

Open PDFView at the publisherCite this paper

In brief

“Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy” is a 2000 journal article by Valerie A. Jenkins and Lesley J. Fallowfield, published in British Journal of Cancer. OpenAlex counts 349 citations as of 22 November 2026, which puts it in the top 2% of works published in 2000 by citations. It is open access under a CC BY-NC-SA licence: the full text is free to read at British Journal of Cancer.

Citations
349
Most cited in
2021 (22)
Field-weighted impact
5.39
References
23
Authors
2

Abstract

This paper reports on the reasons why patients agreed to or declined entry into randomized trials of cancer following discussions conducted by clinicians in both District General and University Hospitals. Two hundred and four patients completed a 16-item questionnaire following the consultation, of these 112 (55%) were women with breast cancer. Overall results showed that 147 (72.1%) patients accepted entry to a randomized clinical trial (RCT). The main reasons nominated for participating in a trial were that 'others will benefit' (23.1%) and 'trust in the doctor' (21.1%). One of the main reasons for declining trial entry was that patients were 'worried about randomization' (19.6%). There was a significantly higher acceptance rate for trials providing active treatment in every arm 98 (80.6%) compared with those trials with a no treatment arm 46 (60.5%), chi2 test P= 0.003. The study outlines a number of factors that appear to influence a patient's decision to accept or decline entry into an RCT of cancer therapy. An important factor is whether or not the trial offers active treatment in all arms of the study. Communication that promotes trust and confidence in the doctor is also a powerful motivating influence.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Jenkins, V. A., & Fallowfield, L. J. (2000). Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. British Journal of Cancer, 82(11), 1783–1788. https://doi.org/10.1054/bjoc.2000.1142

MLA 9

Jenkins, Valerie A., and Lesley J. Fallowfield. “Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy.” British Journal of Cancer, vol. 82, no. 11, 2000, pp. 1783–1788. https://doi.org/10.1054/bjoc.2000.1142.

Chicago

Jenkins, Valerie A. and Lesley J. Fallowfield. 2000. “Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy.” British Journal of Cancer 82 (11): 1783–1788. https://doi.org/10.1054/bjoc.2000.1142.

Harvard

Jenkins, V. A. and Fallowfield, L. J. (2000) ‘Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy’, British Journal of Cancer, 82(11), pp. 1783–1788. doi:10.1054/bjoc.2000.1142.

IEEE

V. A. Jenkins and L. J. Fallowfield, “Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy,” British Journal of Cancer, vol. 82, no. 11, pp. 1783–1788, 2000, doi: 10.1054/bjoc.2000.1142.

BibTeX

@article{jenkins2000reasons,
  title     = {{Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy}},
  author    = {Jenkins, Valerie A. and Fallowfield, Lesley J.},
  journal   = {British Journal of Cancer},
  year      = {2000},
  volume    = {82},
  number    = {11},
  pages     = {1783--1788},
  doi       = {10.1054/bjoc.2000.1142},
  url       = {https://doi.org/10.1054/bjoc.2000.1142}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20171717
20181111
201999
20202020
20212222
202299
20231515
20241313
20251010
202677

Its field-weighted citation impact is 5.39: it has been cited 5.39 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research

  • randomized controlled trials
  • cancer patients
  • clinical trial participation
  • patient decision-making
  • trust in physicians
  • breast cancer
  • clinician-patient communication
  • informed consent

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Jenkins, V. A., & Fallowfield, L. J. (2000). Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. British Journal of Cancer, 82(11), 1783–1788. https://doi.org/10.1054/bjoc.2000.1142

How many times has this paper been cited?

349 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at British Journal of Cancer: sign in and open the PDF from this page.

Who wrote this paper?

Valerie A. Jenkins, Lesley J. Fallowfield.

What is the DOI of this paper?

10.1054/bjoc.2000.1142, permanently at https://doi.org/10.1054/bjoc.2000.1142. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.